NUCLIDIUM AG, a clinical-stage radiopharmaceutical company, today announced that the first patient has been successfully imaged in a Phase 2 clinical trial evaluating the diagnostic accuracy and ...

For men diagnosed with localized prostate cancer, radiation treatment has long meant a difficult trade-off: either endure ...

Considering Protaflo for your daily prostate support routine? Explore the brand-stated probiotic and botanical formula, package pricing, and advertised 90-day guarantee terms to help decide whether it ...

DSS Takara Bio supports prostate cancer research through molecular profiling, transcriptomics and sequencing technologies for ...

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver ...

FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating 68Ga-PSMA-PET imaging alongside MRI in the pre-biopsy prostate cancer setting.The designation recognizes the program ...

Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging. Melbourne (Australia) and Indianapolis, IN (United States) \| September 30, 2026. FDA Fast T ...

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided, biotech/life sciences company focused on advancing novel and potentially ...

New once-daily formula combines Chinese ginseng, cayenne pepper, damiana, saw palmetto, muira puama, epimedium ...

Source: Getty Images During Prostate Cancer Awareness Month, urologists should not stop at discussing diagnosis with their patients but also candidly discuss survivorship after radical prostatectomy.